Placulumab: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
No edit summary |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 13:05, 18 March 2025
| Placulumab | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 945781-29-3 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | D10320 |
Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.<ref>Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association.</ref>
This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.
References[edit]
<references/>
This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!
